OTCM
INLB
Market cap0kUSD
Apr 09, Last price
0.00USD
Name
Item 9 Labs Corp
Chart & Performance
Profile
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|
2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | 2015‑09 | |
Income | ||||||||
Revenues | 21,757 -0.82% | |||||||
Cost of revenue | 33,275 | |||||||
Unusual Expense (Income) | ||||||||
NOPBT | (11,518) | |||||||
NOPBT Margin | ||||||||
Operating Taxes | 13 | |||||||
Tax Rate | ||||||||
NOPAT | (11,532) | |||||||
Net income | (31,179) 92.56% | |||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 658 | |||||||
BB yield | -1.74% | |||||||
Debt | ||||||||
Debt current | 19,946 | |||||||
Long-term debt | 8,854 | |||||||
Deferred revenue | 336 | |||||||
Other long-term liabilities | (7,217) | |||||||
Net debt | 20,996 | |||||||
Cash flow | ||||||||
Cash from operating activities | (2,254) | |||||||
CAPEX | (5,458) | |||||||
Cash from investing activities | (5,160) | |||||||
Cash from financing activities | 6,046 | |||||||
FCF | (4,746) | |||||||
Balance | ||||||||
Cash | 86 | |||||||
Long term investments | 7,718 | |||||||
Excess cash | 6,716 | |||||||
Stockholders' equity | (65,027) | |||||||
Invested Capital | 145,832 | |||||||
ROIC | ||||||||
ROCE | ||||||||
EV | ||||||||
Common stock shares outstanding | 95,691 | |||||||
Price | 0.40 -75.16% | |||||||
Market cap | 37,798 -69.75% | |||||||
EV | 58,773 | |||||||
EBITDA | (9,596) | |||||||
EV/EBITDA | ||||||||
Interest | 6,415 | |||||||
Interest/NOPBT |